Skip to main content

Biobank counters critics

Rebuttal for scientists who question cost-effectiveness of huge UK gene project

Written byPat Hagan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

The UK Biobank project could cost billions of pounds without producing any useful results, according to Alec Jeffreys, the scientist best known for inventing DNA fingerprinting.

In the Daily Telegraph newspaper on September 6, Jeffreys said the costs of identifying millions of genetic markers from all 500,000 volunteers would be excessive. Focused studies on specific diseases such as diabetes or cancer could be more cost effective, he said.

"The project could soak up billions (of pounds), quite easily," Jeffreys was reported as saying. "My concern is whether a study constructed in that way will be effective at teasing out really quite subtle genetic factors influencing disease."

Jeffreys' concerns were backed up by David Goldstein, professor of genetics at University College London, who told The Scientist he fears the £65.1 million Biobank initiative is too big to produce the best scientific results.

"I am not persuaded that this is value for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays